Cargando…

Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer

[Image: see text] Prostate cancer (PCa) is one of the most common malignancies in men and seriously threatens men’s health. Developing aptamer probes for PCa cells is of great significance for early diagnosis and treatment of PCa. This paper reports a classification model for SELEX-based aptamers, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xinliang, Yang, Huiqiong, Huang, Xianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644987/
https://www.ncbi.nlm.nih.gov/pubmed/31459128
http://dx.doi.org/10.1021/acsomega.8b01464
_version_ 1783437363671728128
author Yu, Xinliang
Yang, Huiqiong
Huang, Xianwei
author_facet Yu, Xinliang
Yang, Huiqiong
Huang, Xianwei
author_sort Yu, Xinliang
collection PubMed
description [Image: see text] Prostate cancer (PCa) is one of the most common malignancies in men and seriously threatens men’s health. Developing aptamer probes for PCa cells is of great significance for early diagnosis and treatment of PCa. This paper reports a classification model for SELEX-based aptamers, which were obtained with PCa cell line PCa-3M-1E8 (highly metastatic tumor cell) as target cells and PCa cell line PCa-3M-2B4 (low metastatic tumor cell) as control cells. On the basis of the SELEX principle, 100 oligonucleotide sequences from the 3rd round of SELEX were defined as low affinity and specificity aptamers, and 100 sequences from the 11th round were set as high affinity and specificity aptamers. Seven molecular descriptors were used for the classification model, which were calculated from amino acid sequences translated from DNA aptamer sequences with DNAMAN software. The classification model based on binary logical regression analysis has prediction accuracies, sensitivity, and specificity of about 80% for both the training set and test set. Therefore, it is feasible to calculate molecular descriptors from amino acid sequence translated from DNA aptamer sequences and develop a classification model for PCa cell line PCa-3M-1E8.
format Online
Article
Text
id pubmed-6644987
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-66449872019-08-27 Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer Yu, Xinliang Yang, Huiqiong Huang, Xianwei ACS Omega [Image: see text] Prostate cancer (PCa) is one of the most common malignancies in men and seriously threatens men’s health. Developing aptamer probes for PCa cells is of great significance for early diagnosis and treatment of PCa. This paper reports a classification model for SELEX-based aptamers, which were obtained with PCa cell line PCa-3M-1E8 (highly metastatic tumor cell) as target cells and PCa cell line PCa-3M-2B4 (low metastatic tumor cell) as control cells. On the basis of the SELEX principle, 100 oligonucleotide sequences from the 3rd round of SELEX were defined as low affinity and specificity aptamers, and 100 sequences from the 11th round were set as high affinity and specificity aptamers. Seven molecular descriptors were used for the classification model, which were calculated from amino acid sequences translated from DNA aptamer sequences with DNAMAN software. The classification model based on binary logical regression analysis has prediction accuracies, sensitivity, and specificity of about 80% for both the training set and test set. Therefore, it is feasible to calculate molecular descriptors from amino acid sequence translated from DNA aptamer sequences and develop a classification model for PCa cell line PCa-3M-1E8. American Chemical Society 2018-08-28 /pmc/articles/PMC6644987/ /pubmed/31459128 http://dx.doi.org/10.1021/acsomega.8b01464 Text en Copyright © 2018 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Yu, Xinliang
Yang, Huiqiong
Huang, Xianwei
Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer
title Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer
title_full Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer
title_fullStr Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer
title_full_unstemmed Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer
title_short Novel Method for Structure–Activity Relationship of Aptamer Sequences for Human Prostate Cancer
title_sort novel method for structure–activity relationship of aptamer sequences for human prostate cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644987/
https://www.ncbi.nlm.nih.gov/pubmed/31459128
http://dx.doi.org/10.1021/acsomega.8b01464
work_keys_str_mv AT yuxinliang novelmethodforstructureactivityrelationshipofaptamersequencesforhumanprostatecancer
AT yanghuiqiong novelmethodforstructureactivityrelationshipofaptamersequencesforhumanprostatecancer
AT huangxianwei novelmethodforstructureactivityrelationshipofaptamersequencesforhumanprostatecancer